PMID- 12805069 OWN - NLM STAT- MEDLINE DCOM- 20031029 LR - 20210206 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 102 IP - 7 DP - 2003 Oct 1 TI - Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. PG - 2645-52 AB - Protease-activated receptors (PARs) are stimulated by proteolytic cleavage of their extracellular domain, unmasking a new N-terminus acting as tethered ligand. Whereas the role of PARs in platelets is well known, their presence and function in human monocytes and other antigen-presenting cells has not been characterized. Here it is demonstrated that human peripheral monocytes and monocyte-derived macrophages and dendritic cells differentially express PARs. Human monocytes express mainly PAR1 and less PAR3. Differentiation of monocytes into macrophages by either macrophage colony-stimulating factor (M-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) elicits enhanced expression of PAR1, PAR2, and PAR3. In contrast, dendritic cells differentiated from monocytes by GM-CSF and interleukin-4 (IL-4) strongly down-regulated PAR1, PAR2, and PAR3, both at the mRNA and the protein level. Down-regulation of the PAR expression was apparently due to IL-4, because treatment of macrophages with IL-4 caused down-regulation of PAR1, PAR2, and PAR3. PAR4 mRNA expression remained undetectable in any of the cell types investigated. Stimulation of PAR1, PAR2, and PAR3 with thrombin, trypsin, or established receptor-activating peptides (PAR-APs) triggered cytosolic Ca2+ responses, indicating functionally active PARs. Further, stimulation of monocytes or macrophages with thrombin or PAR1-AP, but not with PAR2-or PAR4-AP, triggers expression of monocyte chemoattractant protein-1 (MCP-1) both at the mRNA and the protein level. These data demonstrate that differentiation of human monocytes is associated with differential expression of functionally active PARs that mediate distinct regulatory functions in inflammation and atherogenesis. FAU - Colognato, Renato AU - Colognato R AD - Department of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, Germany. FAU - Slupsky, Joseph R AU - Slupsky JR FAU - Jendrach, Marina AU - Jendrach M FAU - Burysek, Ladislav AU - Burysek L FAU - Syrovets, Tatiana AU - Syrovets T FAU - Simmet, Thomas AU - Simmet T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20030612 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Chemokine CCL2) RN - 0 (Hemostatics) RN - 0 (Receptor, PAR-1) RN - 0 (Receptor, PAR-2) RN - 0 (Receptors, Thrombin) RN - 0 (protease-activated receptor 3) RN - 207137-56-2 (Interleukin-4) RN - EC 3.4.21.5 (Thrombin) RN - JWE1M73YZN (protease-activated receptor 4) SB - IM MH - Antigen-Presenting Cells/cytology/*physiology MH - Calcium Signaling/immunology MH - Cells, Cultured MH - Chemokine CCL2/genetics MH - Dendritic Cells/cytology/physiology MH - Down-Regulation/drug effects/immunology MH - Gene Expression/drug effects/immunology MH - Hemostatics/pharmacology MH - Humans MH - Interleukin-4/pharmacology MH - Macrophages/cytology/physiology MH - Monocytes/cytology/*physiology MH - Receptor, PAR-1 MH - Receptor, PAR-2 MH - Receptors, Thrombin/*genetics/*metabolism MH - Thrombin/pharmacology EDAT- 2003/06/14 05:00 MHDA- 2003/10/30 05:00 CRDT- 2003/06/14 05:00 PHST- 2003/06/14 05:00 [pubmed] PHST- 2003/10/30 05:00 [medline] PHST- 2003/06/14 05:00 [entrez] AID - S0006-4971(20)44100-X [pii] AID - 10.1182/blood-2002-08-2497 [doi] PST - ppublish SO - Blood. 2003 Oct 1;102(7):2645-52. doi: 10.1182/blood-2002-08-2497. Epub 2003 Jun 12.